SELLAS Life Sciences Group Inc (SLS)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
May 03, 16:00
1.315
-0.02
(-1.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Accounts Payable (Quarterly): 5.639M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.639M |
September 30, 2023 | 4.34M |
June 30, 2023 | 3.734M |
March 31, 2023 | 3.099M |
December 31, 2022 | 3.357M |
September 30, 2022 | 2.127M |
June 30, 2022 | 3.339M |
March 31, 2022 | 2.842M |
December 31, 2021 | 2.144M |
September 30, 2021 | 2.545M |
June 30, 2021 | 2.276M |
March 31, 2021 | 2.35M |
December 31, 2020 | 4.657M |
September 30, 2020 | 1.779M |
June 30, 2020 | 2.426M |
March 31, 2020 | 2.624M |
December 31, 2019 | 3.902M |
September 30, 2019 | 3.764M |
June 30, 2019 | 3.762M |
March 31, 2019 | 4.638M |
December 31, 2018 | 3.755M |
September 30, 2018 | 7.238M |
June 30, 2018 | 12.10M |
March 31, 2018 | 11.45M |
December 31, 2017 | 11.69M |
Date | Value |
---|---|
September 30, 2017 | 0.211M |
June 30, 2017 | 0.385M |
March 31, 2017 | 1.163M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.894M |
June 30, 2016 | 1.273M |
March 31, 2016 | 1.019M |
December 31, 2015 | 1.597M |
September 30, 2015 | 1.238M |
June 30, 2015 | 2.318M |
March 31, 2015 | 3.293M |
December 31, 2014 | 1.886M |
September 30, 2014 | 3.36M |
June 30, 2014 | 2.036M |
March 31, 2014 | 1.574M |
December 31, 2013 | 2.66M |
September 30, 2013 | 1.89M |
June 30, 2013 | 2.092M |
March 31, 2013 | 2.123M |
December 31, 2012 | 1.976M |
September 30, 2012 | 2.21M |
June 30, 2012 | 1.706M |
March 31, 2012 | 2.581M |
December 31, 2011 | 2.155M |
September 30, 2011 | 1.462M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.779M
Minimum
Sep 2020
5.639M
Maximum
Dec 2023
3.195M
Average
3.099M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
Geron Corp | 9.992M |
Immuneering Corp | 2.112M |
Protagonist Therapeutics Inc | 0.772M |
Akebia Therapeutics Inc | 14.64M |
Moderna Inc | 183.00M |